
亚太地区免疫诊断市场预测至 2030 年 - 区域分析 - 按产品(酶联免疫吸附测定 (ELISA)、化学发光免疫测定 (CLIA)、放射免疫测定 (RIA) 等)、按临床适应症(传染病、肝炎+HIV、内分泌学) 、胃肠道、代谢等)和最终用户(医院、诊所、诊断实验室、学术和研究机构等)
No. of Pages: 225 | Report Code: BMIRE00027857 | Category: Life Sciences
No. of Pages: 225 | Report Code: BMIRE00027857 | Category: Life Sciences
当前免疫诊断的趋势是具有商业化潜力的微流控和磁珠。这些灵敏、特异且节省时间的方法对于了解和诊断健康状况(例如传染病、代谢紊乱和心脏问题)至关重要。
免疫诊断学的应用不断增加解决方案鼓励开发有针对性的治疗方法和精准健康疗法。著名的市场参与者还推广检测技术、微流体和磁珠。对于免疫测定,磁性颗粒(例如 Sera-Mag 磁珠)为基于板的 ELISA 提供了便捷的替代方案,因为两者都依赖于相同的测定原理。 Merck KGaA 推出了 Magna Chip Protein A 磁珠。这种重组 Protein A 与磁珠共价结合,用于染色质免疫沉淀(芯片测定),为用户提供比琼脂糖珠更快、可重复且更有效的免疫复合物收集试剂。
在微流体学中,一些免疫诊断针对单一生物标志物。然而,最近的趋势表明,根据复杂性和早期可靠诊断的需要来检测多种分析物。
2023 年 9 月,西门子 Healthineers 发布了其新的 CE 标志SARS-CoV-2/FluA/FluB/HRSV 检测、PCR 检测和 CLINITEST 快速 COVID-19 + 流感抗原检测。新的 FTD SARS-CoV-2/FluA/FluB/HRSV 检测能够对季节性呼吸道病原体进行全面、半自动化的分子检测。组合 PCR 检测可检测和区分临床相关病毒,例如 SARS-CoV-2、甲型流感、乙型流感和 HRSV A/B。
根据 Statista 的数据,2020 年中国很大一部分人口患有慢性病。近 80% 的死亡发生在 60 岁以上的人群中。该国是由慢性非传染性疾病引起的,其中最严重的是缺血性心脏病、中风、慢性阻塞性肺病(COPD)和二型糖尿病。据《中国蓝图》显示,免疫诊断已超过生化诊断(占比27%),体外诊断(IVD)市场已成为中国主流。但与发达国家相比,我国免疫诊断市场的替代生化诊断仍有拓展空间,据多家机构统计,生化与免疫诊断的平均比例约为1:2。随着技术创新的进步以及对高端检测的需求不断增长,诊断预计将巩固其主流地位。
此外,组织之间在开发和生产检测方法方面的合作也在不断增加。例如,2023 年 12 月,Ortho Clinical Diagnostics Trading 和上海麦康生物技术有限公司签署了一项协议,作为合资企业的一部分,在中国开发和制造 VITROS 免疫诊断平台的检测方法。 Ortho Clinical Diagnostics Trading 在开发和设计用于 POC 设置、临床实验室和输血医学的体外诊断 (IVD) 技术方面的专业知识将推动亚太地区免疫诊断市场在未来几年的增长。
< /span>
亚太地区免疫诊断市场细分
亚太地区免疫诊断市场细分为产品、临床适应症、最终用户和国家。
根据产品,亚太地区免疫诊断市场分为酶联免疫吸附测定(ELISA)、化学发光免疫测定( CLIA)、放射免疫分析(RIA)等。 2023年,酶联免疫吸附测定(ELISA)领域在亚太免疫诊断市场中占据最大份额。化学发光免疫分析(CLIA)细分市场进一步细分为维生素D分析市场、HIV检测市场、HIV ag/ab组合分析市场和其他测试。
基于临床适应症亚太地区免疫诊断市场细分为传染病、艾滋病毒肝炎、内分泌、胃肠道、代谢等。 2023年,传染病领域在亚太免疫诊断市场中占据最大份额。传染病细分为 COVID-19、结核病、莱姆病、感染管理、寨卡病毒、密螺旋体、火炬、麻疹和腮腺炎、水痘带状疱疹病毒和 EB 病毒。内分泌领域进一步细分为高血压、生长、糖尿病、甲状腺和生殖内分泌。
根据最终用户,亚太地区免疫诊断市场细分为医院、诊所、诊断实验室、学术和实验室研究机构等。 2023年,医院细分市场在亚太免疫诊断市场中占据最大份额。
按国家/地区划分,亚太免疫诊断市场分为中国、日本、印度、澳大利亚、韩国以及亚太地区其他地区。 2023年,中国在亚太免疫诊断市场占据最大份额。
雅培实验室;生物梅里埃公司;丹纳赫公司; DiaSorin SpA; F.霍夫曼-拉罗氏有限公司;珀金埃尔默公司;深圳迈瑞生物医疗电子有限公司;西门子医疗保健有限公司;斯瓦尔生命科学公司;和 Thermo Fisher Scientific Inc 是亚太免疫诊断市场上的一些领先公司。
Strategic insights for Asia Pacific Immunodiagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 2,409.90 Million |
Market Size by 2030 | US$ 4,252.35 Million |
Global CAGR (2023 - 2030) | 8.5% |
Historical Data | 2021-2022 |
Forecast period | 2024-2030 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Immunodiagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Immunodiagnostics Market is valued at US$ 2,409.90 Million in 2023, it is projected to reach US$ 4,252.35 Million by 2030.
As per our report Asia Pacific Immunodiagnostics Market, the market size is valued at US$ 2,409.90 Million in 2023, projecting it to reach US$ 4,252.35 Million by 2030. This translates to a CAGR of approximately 8.5% during the forecast period.
The Asia Pacific Immunodiagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Immunodiagnostics Market report:
The Asia Pacific Immunodiagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Immunodiagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Immunodiagnostics Market value chain can benefit from the information contained in a comprehensive market report.